Correvio Pharma Corp. Total Liabilities and Equity
Correvio Pharma Corp. had Total Liabilities and Equity of $58.89 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2020-04-30
- 2019-12-31: Liabilities and Equity $58.89M.
- 2018-12-31: Liabilities and Equity $59.64M.
- 2017-12-31: Liabilities and Equity $66.81M.
- 2016-12-31: Liabilities and Equity $67.06M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2019-12-31 | $58.89M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $59.64M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $66.81M 40-F · filed 2019-03-13 | |
| 2016-12-31 | $67.06M 20-F · filed 2018-04-30 | |
| 2015-12-31 | $48.23M 40-F · filed 2017-03-29 | $48.63M 40-F · filed 2016-03-29 |
| 2014-12-31 | $50.12M 40-F · filed 2016-03-29 | |
| 2013-12-31 | $47.33M 40-F · filed 2015-03-27 | |
| 2012-12-31 | $44.79M 40-F/A · filed 2014-04-30 | |
| 2011-12-31 | $54.03M 20-F/A · filed 2013-04-18 | |
| 2010-12-31 | $82.32M 40-F/A · filed 2012-04-25 |